PSEN2
Presenilin-2 jest protein koji je kod ljudi kodiran genom PSEN2 sa hromosoma 1.[5]
Aminokiselinska sekvenca
urediDužina polipeptidnog lanca je 448 aminokiselina, a molekulska težina 50.140 Da.[6]
10 | 20 | 30 | 40 | 50 | ||||
---|---|---|---|---|---|---|---|---|
MLTFMASDSE | EEVCDERTSL | MSAESPTPRS | CQEGRQGPED | GENTAQWRSQ | ||||
ENEEDGEEDP | DRYVCSGVPG | RPPGLEEELT | LKYGAKHVIM | LFVPVTLCMI | ||||
VVVATIKSVR | FYTEKNGQLI | YTPFTEDTPS | VGQRLLNSVL | NTLIMISVIV | ||||
VMTIFLVVLY | KYRCYKFIHG | WLIMSSLMLL | FLFTYIYLGE | VLKTYNVAMD | ||||
YPTLLLTVWN | FGAVGMVCIH | WKGPLVLQQA | YLIMISALMA | LVFIKYLPEW | ||||
SAWVILGAIS | VYDLVAVLCP | KGPLRMLVET | AQERNEPIFP | ALIYSSAMVW | ||||
TVGMAKLDPS | SQGALQLPYD | PEMEEDSYDS | FGEPSYPEVF | EPPLTGYPGE | ||||
ELEEEEERGV | KLGLGDFIFY | SVLVGKAAAT | GSGDWNTTLA | CFVAILIGLC | ||||
LTLLLLAVFK | KALPALPISI | TFGLIFYFST | DNLVRPFMDT | LASHQLYI |
Funkcija
urediKod Alzheimerove bolesti (AD), pacijenti sa naslijeđenim oblikom nose mutacije u presenilinskim proteinima (PSEN1; PSEN2) ili amiloidnom prekursoru proteina (APP). Ove mutacije povezane sa bolešću rezultiraju povećanom proizvodnjom dužeg oblika varijante amiloid-beta (glavna komponenta amiloidnih naslaga pronađenih u mozgu AD). Pretpostavlja se da presenilini reguli procesiranje APP kroz svoje efekte na gama-sekretazu, enzim koji cijepa APP. Takođe, smatra se da su presenilini uključeni u cepanje Notch receptora, tako da oni ili direktno regulišu aktivnost gama-sekretaze ili su sami proteaza enzimi. Identifikovana su dva alternativna transkripta PSEN2.[7]
U melanocitnim ćelijama, ekspresija gena PSEN2 može biti regulirana MITF-om.[8]
Interakcije
urediPokazalo se da PSEN2 u u interakciji sa:
Reference
uredi- ^ a b c GRCh38: Ensembl release 89: ENSG00000143801 - Ensembl, maj 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000010609 - Ensembl, maj 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K (septembar 1995). "Candidate gene for the chromosome 1 familial Alzheimer's disease locus". Science. 269 (5226): 973–977. Bibcode:1995Sci...269..973L. doi:10.1126/science.7638622. PMID 7638622. S2CID 27296868.
- ^ "UniProt, P49810" (jezik: engleski). Pristupljeno 16. 12. 2021.
- ^ "Entrez Gene: PSEN2 presenilin 2 (Alzheimer disease 4)".
- ^ Hoek KS, Schlegel NC, Eichhoff OM, Widmer DS, Praetorius C, Einarsson SO, Valgeirsdottir S, Bergsteinsdottir K, Schepsky A, Dummer R, Steingrimsson E (2008). "Novel MITF targets identified using a two-step DNA microarray strategy". Pigment Cell Melanoma Res. 21 (6): 665–676. doi:10.1111/j.1755-148X.2008.00505.x. PMID 19067971.
- ^ Passer BJ, Pellegrini L, Vito P, Ganjei JK, D'Adamio L (august 1999). "Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death". J. Biol. Chem. 274 (34): 24007–13. doi:10.1074/jbc.274.34.24007. PMID 10446169.
- ^ Shinozaki K, Maruyama K, Kume H, Tomita T, Saido TC, Iwatsubo T, Obata K (maj 1998). "The presenilin 2 loop domain interacts with the mu-calpain C-terminal region". Int. J. Mol. Med. 1 (5): 797–9. doi:10.3892/ijmm.1.5.797. PMID 9852298.
- ^ Stabler SM, Ostrowski LL, Janicki SM, Monteiro MJ (juni 1999). "A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein". J. Cell Biol. 145 (6): 1277–92. doi:10.1083/jcb.145.6.1277. PMC 2133148. PMID 10366599.
- ^ Buxbaum JD, Choi EK, Luo Y, Lilliehook C, Crowley AC, Merriam DE, Wasco W (oktobar 1998). "Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment". Nat. Med. 4 (10): 1177–81. doi:10.1038/2673. PMID 9771752. S2CID 10799492.
- ^ Choi EK, Zaidi NF, Miller JS, Crowley AC, Merriam DE, Lilliehook C, Buxbaum JD, Wasco W (juni 2001). "Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2". J. Biol. Chem. 276 (22): 19197–204. doi:10.1074/jbc.M008597200. PMID 11278424.
- ^ Tanahashi H, Tabira T (septembar 2000). "Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein". Hum. Mol. Genet. 9 (15): 2281–9. doi:10.1093/oxfordjournals.hmg.a018919. PMID 11001931.
- ^ Zhang W, Han SW, McKeel DW, Goate A, Wu JY (februar 1998). "Interaction of presenilins with the filamin family of actin-binding proteins". J. Neurosci. 18 (3): 914–22. doi:10.1523/JNEUROSCI.18-03-00914.1998. PMC 2042137. PMID 9437013.
- ^ Morohashi Y, Hatano N, Ohya S, Takikawa R, Watabiki T, Takasugi N, Imaizumi Y, Tomita T, Iwatsubo T (april 2002). "Molecular cloning and characterization of CALP/KChIP4, a novel EF-hand protein interacting with presenilin 2 and voltage-gated potassium channel subunit Kv4". J. Biol. Chem. 277 (17): 14965–75. doi:10.1074/jbc.M200897200. PMID 11847232.
- ^ Lee SF, Shah S, Li H, Yu C, Han W, Yu G (novembar 2002). "Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch". J. Biol. Chem. 277 (47): 45013–9. doi:10.1074/jbc.M208164200. PMID 12297508.
- ^ Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song YQ, Rogaeva E, Chen F, Kawarai T, Supala A, Levesque L, Yu H, Yang DS, Holmes E, Milman P, Liang Y, Zhang DM, Xu DH, Sato C, Rogaev E, Smith M, Janus C, Zhang Y, Aebersold R, Farrer LS, Sorbi S, Bruni A, Fraser P, St George-Hyslop P (septembar 2000). "Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing". Nature. 407 (6800): 48–54. Bibcode:2000Natur.407...48Y. doi:10.1038/35024009. PMID 10993067. S2CID 4339220.
- ^ Mah AL, Perry G, Smith MA, Monteiro MJ (novembar 2000). "Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation". J. Cell Biol. 151 (4): 847–62. doi:10.1083/jcb.151.4.847. PMC 2169435. PMID 11076969.
Dopunska literatura
uredi- Cruts M, Van Broeckhoven C (1998). "Presenilin mutations in Alzheimer's disease". Hum. Mutat. 11 (3): 183–190. doi:10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.0.CO;2-J. PMID 9521418.
- McGeer PL, Kawamata T, McGeer EG (1998). "Localization and possible functions of presenilins in brain". Reviews in the Neurosciences. 9 (1): 1–15. doi:10.1515/REVNEURO.1998.9.1.1. PMID 9683324. S2CID 22791458.
- Nishimura M, Yu G, St George-Hyslop PH (1999). "Biology of presenilins as causative molecules for Alzheimer disease". Clin. Genet. 55 (4): 219–225. doi:10.1034/j.1399-0004.1999.550401.x. PMID 10361981. S2CID 35128500.
- da Costa CA (2006). "Recent insights on the pro-apoptotic phenotype elicited by presenilin 2 and its caspase and presenilinase-derived fragments". Current Alzheimer Research. 2 (5): 507–514. doi:10.2174/156720505774932278. PMID 16375654.
- Wolfe MS (2007). "When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease". EMBO Rep. 8 (2): 136–140. doi:10.1038/sj.embor.7400896. PMC 1796780. PMID 17268504.
- De Strooper B (2007). "Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease". EMBO Rep. 8 (2): 141–146. doi:10.1038/sj.embor.7400897. PMC 1796779. PMID 17268505.